Comparation of vancomycin penetration into cerebrospinal fluid in postoperative intracranial infection and community-acquired meningitis patients

J Clin Pharm Ther. 2019 Apr;44(2):216-219. doi: 10.1111/jcpt.12770. Epub 2018 Oct 27.

Abstract

What is known and objective: To compare the penetration of vancomycin into cerebrospinal fluid (CSF) in patients with postoperative intracranial infection and community-acquired meningitis, and to identify related factors influencing the penetration in these two diseases.

Methods: The concentrations of vancomycin in serum and CSF were determined by enzyme amplified immunoassay, and the CSF-to-serum ratios were calculated. The correlation between CSF-to-serum ratios of vancomycin and CSF elements was analyzed.

Results and discussion: In postoperative intracranial infection patients and community-acquired meningitis patients, the vancomycin concentration in CSF was 1.90 ± 1.29 mg/L and 2.47 ± 1.15 mg/L, while the CSF-to-serum ratio was 0.19 ± 0.12 and 0.26 ± 0.12, respectively. There was a significant correlation between vancomycin serum concentration and bodyweight (P < 0.05). The CSF-to-serum ratio in postoperative intracranial infection patients was correlated to white blood cell count in CSF. However, in community-acquired meningitis patients, no relationship was seen with regards to CSF white blood cell count, protein or glucose.

What is new and conclusion: Cerebrospinal fluid vancomycin penetration was similar in postoperative intracranial infection and community-acquired meningitis patients. The CSF-to-serum ratio was only correlated to CSF white blood cell count in postoperative intracranial infection patients.

Keywords: cerebrospinal fluid; community-acquired meningitis; postoperative intracranial infection; therapeutic drug monitoring; vancomycin.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / cerebrospinal fluid*
  • Central Nervous System Bacterial Infections / drug therapy*
  • Community-Acquired Infections / drug therapy
  • Female
  • Humans
  • Leukocyte Count
  • Male
  • Meningitis, Bacterial / drug therapy*
  • Middle Aged
  • Postoperative Complications / drug therapy
  • Postoperative Complications / microbiology
  • Vancomycin / administration & dosage
  • Vancomycin / cerebrospinal fluid*
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Vancomycin